1958 related articles for article (PubMed ID: 8386711)
1. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5.
Rivoltini L; Viggiano V; Spinazzè S; Santoro A; Colombo MP; Takatsu K; Parmiani G
Int J Cancer; 1993 Apr; 54(1):8-15. PubMed ID: 8386711
[TBL] [Abstract][Full Text] [Related]
2. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy.
Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T
Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression.
Gregory B; Kirchem A; Phipps S; Gevaert P; Pridgeon C; Rankin SM; Robinson DS
J Immunol; 2003 Jun; 170(11):5359-66. PubMed ID: 12759409
[TBL] [Abstract][Full Text] [Related]
5. The effect of transendothelial migration on eosinophil function.
Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils.
Koenderman L; Hermans SW; Capel PJ; van de Winkel JG
Blood; 1993 May; 81(9):2413-9. PubMed ID: 8481520
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of tumour necrosis factor alpha mediated eosinophil survival.
Temkin V; Levi-Schaffer F
Cytokine; 2001 Jul; 15(1):20-6. PubMed ID: 11509005
[TBL] [Abstract][Full Text] [Related]
8. [Induction of gene (mRNA) expression of CD23, CD25 and CD4 on eosinophils by eosinophilopoietic growth lymphokines].
Chihara J; Nakajima S
Nihon Rinsho; 1993 Mar; 51(3):581-7. PubMed ID: 8492430
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration.
Erger RA; Casale TB
Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492
[TBL] [Abstract][Full Text] [Related]
10. Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5).
Chihara J; Gruart V; Plumas J; Tavernier J; Kusnierz JP; Prin L; Capron A; Capron M
Eur Cytokine Netw; 1992; 3(1):53-61. PubMed ID: 1533800
[TBL] [Abstract][Full Text] [Related]
11. Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules.
Guarini A; Riera L; Cignetti A; Montacchini L; Massaia M; Foa R
Blood; 1997 Jan; 89(1):212-8. PubMed ID: 8978294
[TBL] [Abstract][Full Text] [Related]
12. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy.
Fabian I; Kravtsov V; Elis A; Gurevitch O; Ackerstein A; Slavin S; Nagler A
Leukemia; 1994 Aug; 8(8):1379-84. PubMed ID: 8057677
[TBL] [Abstract][Full Text] [Related]
14. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.
Tai PC; Sun L; Spry CJ
Clin Exp Immunol; 1991 Aug; 85(2):312-6. PubMed ID: 1864012
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
Young DA; Lowe LD; Clark SC
J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
Luttmann W; Opfer A; Dauer E; Foerster M; Matthys H; Eibel H; Schulze-Osthoff K; Kroegel C; Virchow JC
Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
[TBL] [Abstract][Full Text] [Related]
19. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
Broide DH; Paine MM; Firestein GS
J Clin Invest; 1992 Oct; 90(4):1414-24. PubMed ID: 1401075
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.
Ebisawa M; Liu MC; Yamada T; Kato M; Lichtenstein LM; Bochner BS; Schleimer RP
J Immunol; 1994 May; 152(9):4590-6. PubMed ID: 8157972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
